0.1675EUR-6.94%Mkt Cap: 1.11M EURP/E: —Last update: 2026-06-01
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology an…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.11M EUR
Enterprise Value376.43K EUR
Revenue (TTM)5.02M EUR
Gross Profit5.02M EUR
Net Income (TTM)-171.40K EUR
Revenue/Share0.7610 EUR
Last Price0.1675 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees37
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.14
EV/Revenue0.07
P/S0.24
P/B-1.30
EPS (TTM)-0.04
EPS (Forward)—
52W Range
0.115012% of range0.5700
52W High0.5700 EUR
52W Low0.1150 EUR
Profitability
Gross Margin40.03%
Oper. Margin-56.57%
EBITDA Margin-53.92%
Profit Margin-1.37%
ROE-8.52%
ROA-2.14%
Growth
Revenue Growth-44.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.58M EUR
CapEx (TTM)—
FCF Margin-3.31%
FCF Yield-14.97%
Net Debt-810.61K EUR
Net Debt/EBITDA0.30
Balance Sheet
Debt/Equity0.56
Current Ratio0.95
Quick Ratio0.85
Book Value/Sh-0.1380 EUR
Cash/Share0.1690 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.61M
Float—
Insiders65.90%
Institutions0.00%
Technical
SMA 500.1913 (-12.4%)
SMA 2000.1769 (-5.3%)
Beta0.33
S&P 52W Chg27.94%
Avg Vol (30d)27.22K
Avg Vol (10d)21.32K
Technical Indicators
RSI (14)44.5
MACD-0.0005
MACD Signal0.0067
MACD Hist.-0.0072
BB Upper0.3070 EUR
BB Middle0.2127 EUR
BB Lower0.1184 EUR
BB Width88.66%
ATR (14)0.0261 EUR
Vol Ratio (20d)0.81x